SCHEMBL7960974

SCHEMBL7960974

Fc1cc(Cl)ccc1C1=CCN(CCCc2nnc3n2CCCCC3)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.45
SHMT2 P34897 1/20 0.45
GAA P10253 2/20 0.44
PKM P14618 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
HPGD P15428 2/20 0.41
POLB P06746 2/20 0.41
PARP1 P09874 3/20 0.40
SIGMAR1 Q99720 2/20 0.38
HTT P42858 1/20 0.38
CHRM2 P08172 1/20 0.37
HTR1A P08908 1/20 0.37
ADRA2A P08913 1/20 0.37
ADRA2B P18089 1/20 0.37
ADRA1D P25100 1/20 0.37
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
SLC6A4 P31645 1/20 0.37
ADRA1A P35348 1/20 0.37
DRD3 P35462 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7958937 0.89 PKM (0.52) LMNASHMT2GAAPKMSMN1; SMN2
SCHEMBL7949039 0.85 SIGMAR1 (0.53) GAAPKMSMN1; SMN2HPGDPARP1
SCHEMBL7949425 0.85 LMNA (0.52) LMNASHMT2GAAPKMSMN1; SMN2
SCHEMBL7959347 0.83 LMNA (0.45) LMNASHMT2GAASMN1; SMN2HPGD
SCHEMBL7949533 0.83 GAA (0.50) GAAPKMSMN1; SMN2HPGDPOLB
SCHEMBL7961207 0.83 POLB (0.44) LMNASHMT2GAASMN1; SMN2POLB
SCHEMBL7957285 0.81 SIGMAR1 (0.53) LMNAPOLBPARP1SIGMAR1
SCHEMBL7959202 0.81 GAA (0.41) LMNASHMT2GAASMN1; SMN2HPGD
SCHEMBL7963975 0.81 L3MBTL1 (0.39) LMNASHMT2GAAPKMSMN1; SMN2
SCHEMBL7964099 0.78 HPGD (0.53) LMNAHPGDPOLBPARP1SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6187774-B1 N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2001-02-13 US disclosed
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP disclosed